54/120
2.3 / 5 stars
All 120 Win/Lose results shown below
GKOS Roast Me summary
GLAUKOS Corp (GKOS). Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.
- 2026-Q2: Total return Win; Revenue growth Win; EPS growth Lose.
- 2026-Q1: Total return Lose; Revenue growth Win; EPS growth Lose.
- 2025-Q4: Total return Win; Revenue growth Win; EPS growth Lose.
- 2025-Q3: Total return Lose; Revenue growth Win; EPS growth Lose.
Trailing 1 year (4 quarters): 6 wins, 6 lossesLast fetched: 25 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q22/3 |
WinGKOS / S&P 29.82% / 15.20% |
WinGKOS / S&P 41.55% / 15.00% |
LoseGKOS / S&P GKOS unavailable / 50.40% |
| 2026-Q11/3 |
LoseGKOS / S&P -4.65% / -4.33% |
WinGKOS / S&P 36.30% / 11.30% |
LoseGKOS / S&P GKOS unavailable / 27.70% |
| 2025-Q42/3 |
WinGKOS / S&P 38.45% / 2.65% |
WinGKOS / S&P 32.33% / 9.00% |
LoseGKOS / S&P GKOS unavailable / 13.40% |
| 2025-Q31/3 |
LoseGKOS / S&P -21.05% / 8.12% |
WinGKOS / S&P 30.38% / 4.61% |
LoseGKOS / S&P GKOS unavailable / 13.45% |
| 2025-Q21/3 |
LoseGKOS / S&P 4.95% / 10.94% |
WinGKOS / S&P 26.70% / 4.83% |
LoseGKOS / S&P GKOS unavailable / 10.63% |
| 2025-Q11/3 |
LoseGKOS / S&P -34.36% / -4.27% |
WinGKOS / S&P 23.92% / 4.98% |
LoseGKOS / S&P GKOS unavailable / 10.57% |
| 2024-Q42/3 |
WinGKOS / S&P 15.09% / 2.41% |
WinGKOS / S&P 21.85% / 5.25% |
LoseGKOS / S&P GKOS unavailable / 6.15% |
| 2024-Q32/3 |
WinGKOS / S&P 10.08% / 5.89% |
WinGKOS / S&P 18.70% / 5.89% |
LoseGKOS / S&P GKOS unavailable / 6.11% |
| 2024-Q22/3 |
WinGKOS / S&P 25.52% / 4.28% |
WinGKOS / S&P 15.14% / 5.38% |
LoseGKOS / S&P GKOS unavailable / 5.12% |
| 2024-Q12/3 |
WinGKOS / S&P 18.62% / 10.56% |
WinGKOS / S&P 12.92% / 5.71% |
LoseGKOS / S&P GKOS unavailable / 5.59% |
| 2023-Q41/3 |
LoseGKOS / S&P 5.63% / 11.69% |
WinGKOS / S&P 11.26% / 6.81% |
LoseGKOS / S&P GKOS unavailable / 7.78% |
| 2023-Q31/3 |
WinGKOS / S&P 5.67% / -3.27% |
LoseGKOS / S&P 6.56% / 7.52% |
LoseGKOS / S&P GKOS unavailable / -5.03% |
| 2023-Q21/3 |
WinGKOS / S&P 42.14% / 8.74% |
LoseGKOS / S&P 2.94% / 9.50% |
LoseGKOS / S&P GKOS unavailable / -8.57% |
| 2023-Q11/3 |
WinGKOS / S&P 14.70% / 7.50% |
LoseGKOS / S&P -1.58% / 10.77% |
LoseGKOS / S&P GKOS unavailable / -15.69% |
| 2022-Q40/3 |
LoseGKOS / S&P -17.96% / 7.56% |
LoseGKOS / S&P -3.79% / 11.88% |
LoseGKOS / S&P GKOS unavailable / -17.99% |
| 2022-Q31/3 |
WinGKOS / S&P 17.22% / -4.88% |
LoseGKOS / S&P -3.11% / 13.47% |
LoseGKOS / S&P GKOS unavailable / -1.41% |
| 2022-Q20/3 |
LoseGKOS / S&P -21.45% / -16.10% |
LoseGKOS / S&P 1.47% / 13.71% |
LoseGKOS / S&P GKOS unavailable / 11.04% |
| 2022-Q12/3 |
WinGKOS / S&P 30.11% / -4.60% |
WinGKOS / S&P 23.63% / 15.97% |
LoseGKOS / S&P GKOS unavailable / 42.23% |
| 2021-Q41/3 |
LoseGKOS / S&P -7.74% / 11.03% |
WinGKOS / S&P 30.70% / 15.00% |
LoseGKOS / S&P GKOS unavailable / 96.40% |
| 2021-Q31/3 |
LoseGKOS / S&P -43.22% / 0.58% |
WinGKOS / S&P 35.13% / 10.77% |
LoseGKOS / S&P GKOS unavailable / 69.42% |
| 2021-Q21/3 |
LoseGKOS / S&P 1.07% / 8.55% |
WinGKOS / S&P 34.50% / 6.58% |
LoseGKOS / S&P GKOS unavailable / 51.81% |
| 2021-Q12/3 |
WinGKOS / S&P 11.52% / 6.17% |
WinGKOS / S&P -0.30% / -1.06% |
LoseGKOS / S&P GKOS unavailable / 7.39% |
| 2020-Q41/3 |
WinGKOS / S&P 51.98% / 12.15% |
LoseGKOS / S&P -5.07% / -3.72% |
LoseGKOS / S&P -829.73% / -33.42% |
| 2020-Q31/3 |
WinGKOS / S&P 28.89% / 8.93% |
LoseGKOS / S&P -3.39% / -2.04% |
LoseGKOS / S&P GKOS unavailable / -27.10% |
| 2020-Q22/3 |
WinGKOS / S&P 24.50% / 20.54% |
WinGKOS / S&P 0.30% / -0.46% |
LoseGKOS / S&P GKOS unavailable / -27.11% |
| 2020-Q11/3 |
LoseGKOS / S&P -43.34% / -19.60% |
WinGKOS / S&P 22.09% / 3.47% |
LoseGKOS / S&P GKOS unavailable / -14.75% |
| 2019-Q41/3 |
LoseGKOS / S&P -12.86% / 9.07% |
WinGKOS / S&P 30.73% / 5.36% |
LoseGKOS / S&P GKOS unavailable / 2.99% |
| 2019-Q31/3 |
LoseGKOS / S&P -17.10% / 1.70% |
WinGKOS / S&P 33.38% / 5.02% |
LoseGKOS / S&P GKOS unavailable / 0.21% |
| 2019-Q21/3 |
LoseGKOS / S&P -3.79% / 4.30% |
WinGKOS / S&P 27.37% / 6.64% |
LoseGKOS / S&P GKOS unavailable / 8.65% |
| 2019-Q12/3 |
WinGKOS / S&P 39.52% / 13.65% |
WinGKOS / S&P 19.39% / 8.12% |
LoseGKOS / S&P GKOS unavailable / 14.29% |
| 2018-Q42/3 |
WinGKOS / S&P -13.45% / -13.52% |
WinGKOS / S&P 13.83% / 9.05% |
LoseGKOS / S&P GKOS unavailable / 18.23% |
| 2018-Q32/3 |
WinGKOS / S&P 59.69% / 7.71% |
WinGKOS / S&P 11.99% / 10.21% |
LoseGKOS / S&P GKOS unavailable / 19.06% |
| 2018-Q22/3 |
WinGKOS / S&P 31.82% / 3.43% |
WinGKOS / S&P 18.16% / 9.03% |
LoseGKOS / S&P GKOS unavailable / 14.46% |
| 2018-Q12/3 |
WinGKOS / S&P 20.19% / -0.76% |
WinGKOS / S&P 28.51% / 7.68% |
LoseGKOS / S&P -200.00% / 12.46% |
| 2017-Q41/3 |
LoseGKOS / S&P -22.27% / 6.64% |
WinGKOS / S&P 39.21% / 7.03% |
LoseGKOS / S&P -100.00% / 13.82% |
| 2017-Q31/3 |
LoseGKOS / S&P -20.42% / 4.48% |
WinGKOS / S&P 48.55% / 5.68% |
LoseGKOS / S&P -105.19% / 17.57% |
| 2017-Q21/3 |
LoseGKOS / S&P -19.16% / 3.09% |
WinGKOS / S&P 53.90% / 4.83% |
LoseGKOS / S&P -107.46% / 17.74% |
| 2017-Q12/3 |
WinGKOS / S&P 49.56% / 6.07% |
WinGKOS / S&P 58.76% / 3.67% |
LoseGKOS / S&P GKOS unavailable / 13.32% |
| 2016-Q41/3 |
LoseGKOS / S&P -9.12% / 3.82% |
WinGKOS / S&P 59.55% / 2.09% |
LoseGKOS / S&P GKOS unavailable / 7.05% |
| 2016-Q32/3 |
WinGKOS / S&P 29.42% / 3.85% |
WinGKOS / S&P 47.91% / 0.20% |
LoseGKOS / S&P GKOS unavailable / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-28
| Metric | GKOS total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 87.64% | 20.78% |
| Annualized return | 87.64% | 20.78% |
5Y · 2021-09-01 to 2026-08-28
| Metric | GKOS total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 208.30% | 83.14% |
| Annualized return | 25.25% | 12.86% |
10Y · 2016-09-01 to 2026-08-28
| Metric | GKOS total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 497.94% | 319.30% |
| Annualized return | 19.58% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-25.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |